BLUE OWL CAPITAL HOLDINGS LP
Q2 2026 Form 13-F

NEW YORK, NEW YORK
CIK 0001858703 · Institutional investment manager
Consolidated report · includes 10 managers since Q2 2023
$664.5M Reported Value Total
Reported value
$664.5M
Quarter over quarter
+14.5%
Holdings
71
Top-10 concentration
78.5%

Reports holdings for

  • Blue Owl Alternative Credit Advisors LLC (not a 13F filer in our records) · since Q3 2024 · declared by one filing
  • Blue Owl CLO Management I LLC (not a 13F filer in our records) · since Q1 2026 · declared by one filing
  • Blue Owl Credit Advisors LLC (not a 13F filer in our records) · since Q2 2023 · declared by one filing
  • Blue Owl Credit Private Fund Advisors LLC (not a 13F filer in our records) · since Q2 2023 · declared by one filing
  • Blue Owl Digital Infrastructure Advisors LLC (not a 13F filer in our records) · since Q2 2026 · declared by one filing
  • Blue Owl GPSC Advisors LLC (not a 13F filer in our records) · since Q2 2023 · declared by one filing
  • Blue Owl GPSC IV Advisors LLC (not a 13F filer in our records) · since Q4 2023 · declared by one filing
  • Blue Owl Healthcare Opportunities Advisors LLC (not a 13F filer in our records) · since Q1 2024 · declared by one filing
  • Blue Owl Insurance Advisors LLC (not a 13F filer in our records) · since Q3 2024 · declared by one filing
  • Blue Owl Technology Credit Advisors LLC (not a 13F filer in our records) · since Q2 2023 · declared by one filing
  • Blue Owl Healthcare Opportunities Advisors (not a 13F filer in our records) · Q4 2023 – Q4 2023 · declared by one filing
  • Dyal Advisors LLC (not a 13F filer in our records) · Q4 2021 – Q1 2023 · declared by one filing
  • Dyal IV Advisors LLC (not a 13F filer in our records) · Q4 2021 – Q1 2023 · declared by one filing
  • Owl Rock Capital Advisors LLC (not a 13F filer in our records) · Q4 2021 – Q1 2023 · declared by one filing
  • Owl Rock Capital Private Fund Advisors LLC (not a 13F filer in our records) · Q4 2021 – Q1 2023 · declared by one filing
  • Owl Rock Technology Advisors LLC (not a 13F filer in our records) · Q4 2021 – Q1 2023 · declared by one filing

Key People

Named on the latest Form 13-F filing — not necessarily an owner
Karen Hager
Chief Compliance Officer
Q1 2026
Loading 13F Metrics

Q2 2026 13F filing summary

Period of report June 30, 2026
Filed August 11, 2026
Form 13F-HR
Reported value $664.5M
Positions 71
Change in reported value +78.6%
New positions 18
Exited positions 22
Position turnover 43.0%
Top-10 concentration 78.5%

13F filings by quarter

Quarter Positions Value
Q2 2026 13F
Filed Aug 11, 2026
 71 $664.5M
Q1 2026 13F
Filed May 14, 2026
 74 $372.2M
Q4 2025 13F
Filed Feb 9, 2026
 78 $324.0M
Q3 2025 13F
Filed Nov 12, 2025
 72 $322.1M
Q2 2025 13F
Filed Aug 11, 2025
 72 $309.9M
Q1 2025 13F
Filed May 15, 2025
 73 $310.1M
Q4 2024 13F
Filed Feb 14, 2025
 78 $434.0M
Q3 2024 13F
Filed Nov 14, 2024
 132 $518.4M
Q2 2024 13F
Filed Aug 15, 2024
 41 $359.6M
Q1 2024 13F
Filed May 15, 2024
 44 $500.6M
Q4 2023 13F
Filed Feb 15, 2024
 42 $418.3M
Q3 2023 13F
Filed Nov 14, 2023
 15 $129.3M
Q2 2023 13F
Filed Aug 11, 2023
 16 $162.3M
Q1 2023 13F
Filed May 11, 2023
 15 $156.1M
Q4 2022 13F
Filed Feb 13, 2023
 43 $235.0M
Q3 2022 13F
Filed Nov 14, 2022
 39 $230.9M
Q2 2022 13F
Filed Aug 12, 2022
 37 $203.6M
Q1 2022 13F
Filed May 16, 2022
 31 $227.2M
Q4 2021 13F
Filed Feb 11, 2022
 25 $218.7M

Top 20 holdings · Q2 2026

# Holding Reported value % of portfolio
1 SPCX SPACE EXPLORATION TECHN CORP $239.0M 35.97%
2 AKTS AKTIS ONCOLOGY INC $99.0M 14.89%
3 CGEM CULLINAN THERAPEUTICS INC $28.0M 4.22%
4 LRMR LARIMAR THERAPEUTICS INC $27.9M 4.21%
5 NCDL NUVEEN CHURCHILL DIRECT LEND $26.6M 4.01%
6 MPLT MAPLIGHT THERAPEUTICS INC $26.2M 3.94%
7 COF CAPITAL ONE FINL CORP $24.0M 3.62%
8 OBDC BLUE OWL CAPITAL CORPORATION $22.2M 3.35%
9 FISN DEEP FISSION INC $14.7M 2.22%
10 DELL DELL TECHNOLOGIES INC $14.2M 2.14%
11 HLLY HOLLEY INC $11.2M 1.68%
12 EYPT EYEPOINT INC $10.9M 1.64%
13 SGMT SAGIMET BIOSCIENCES INC $9.7M 1.47%
14 CRVS CORVUS PHARMACEUTICALS INC $9.1M 1.37%
15 ARTV ARTIVA BIOTHERAPEUTICS INC $8.5M 1.28%
16 CMPX COMPASS THERAPEUTICS INC $7.9M 1.19%
17 CNDT CONDUENT INC $7.4M 1.11%
18 RYTM RHYTHM PHARMACEUTICALS INC $6.8M 1.03%
19 CMPS COMPASS PATHWAYS PLC $6.4M 0.96%
20 RARE ULTRAGENYX PHARMACEUTICAL IN $6.1M 0.92%

Values as reported on the Q2 2026 Form 13F. Every position is in the holdings table below.

Loading Activities
Loading Sector Allocation
Crunching numbers
Loading Performance
Finding Similar Managers
Finding Potential New Buys
Building table
Loading SEC filing data
Loading Form 4 Filings
Loading 13D/G filings